Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterNo recent work listed

Marc Aprahamian

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5111539982. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 2 papers · 2015: none · 2016: none · 2017: 2 papers

Papers 5

  1. Survival variability of controls and definition of imaging endpoints for longitudinal follow-up of pancreatic ductal adenocarcinoma in rats. Last author DOI 10.1007/s00432-016-2265-6↗
  2. Feasibility and reliability of pancreatic cancer staging using a new confocal non-fluorescent microscopy probe: a double-blind study in rats. Co-author DOI 10.1007/s00464-016-5062-z↗
  3. Myo-inositol trispyrophosphate-mediated hypoxia reversion controls pancreatic cancer in rodents and enhances gemcitabine efficacy. Last author DOI 10.1002/ijc.28597↗
  4. Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer. Co-author DOI 10.1128/jvi.03688-13↗
  5. Interferon γ improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer. First author DOI 10.4161/cbt.12.10.17678↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Cherif Youssef Akladios · 2 shared papers, 2017 · strength 0.17
  2. Svitlana P. Grekova · 3 shared papers, 2011–2014 · strength 0.11
  3. Zahari Raykov · 3 shared papers, 2011–2014 · strength 0.11
  4. Nathalia A. Giese · 3 shared papers, 2011–2014 · strength 0.11
  5. Jacques Marescaux · 1 shared paper, 2017 · strength 0.07
  6. Gerlinde Avérous · 1 shared paper, 2017 · strength 0.07
  7. Assia L. Angelova · 2 shared papers, 2011–2014 · strength 0.06
  8. Jens Werner · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.